Cellectar Biosciences, Inc. — Director's Dealing 2018

Aug 18, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cellectar Biosciences, Inc. (CLRB)
CIK: 0001279704
Period of Report: 2018-08-16

Reporting Person: Longcor Jarrod (Chief Business Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-08-16	Common Stock	P	500	$2.71	Acquired	7200	Direct